Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Antioxidants help contain killer bug – Tuberculosis

Antioxidants help contain killer bug – Tuberculosis

Date time 19 March, 2019
News Type News type Media release

Image above: Still image shows red inflammatory immune cells with the blue Tuberculosis bacteria.

Tuberculosis is the single leading cause of death from infectious disease around the world and infects someone every three seconds, causing life-long damage to the lungs.

Research led by Centenary has identified a powerful tool to fight tuberculosis. In collaboration with scientists at the University of Sydney, our team has shown antioxidant drugs both kill mycobacteria, the cause of infection, and keep the immune system from causing too much damage through out-of-control inflammation.

“Tuberculosis is one of the most common inflammatory diseases, and it is the immune systems that do most of the damage to the body during infection,” says senior author and Head of Centenary’s Immune-Vascular Interactions Laboratory, Dr Stefan Oehlers.

Video above: Taken using fluorescent microscopy shows the red inflammatory immune cells attacking blue bacteria outlined by green blood.

Read the full media release

View the full paper

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Download

Recent Stories

  • New insight into liver ‘cross-talk’ could help tackle fatty liver disease

    Researchers from the Centenary Institute and Tianjin Medical University have uncovered an important communication pathway inside the liver that helps control fat build-up, offering a promising new direction for tackling fatty liver disease.
    News Type: Research News
    Date 13 May 2026
  • Blood clotting protein’s hidden complexity revealed

    Researchers at the Centenary Institute have discovered that fibrinogen, a key blood clotting protein, is far more complex than previously understood, offering new insight into how blood clots form in the body.
    News Type: Research News
    Date 30 Apr 2026
  • Researcher spotlight: Dr Tracy Liu

    For Dr Xin (Tracy) Liu, fatty liver disease isn’t just a scientific challenge, it’s personal. Inspired by family members affected by metabolic conditions, she’s now a key member of Australia’s seven‑year Snow Program for Liver Health.
    News Type: Profiles
    Date 24 Apr 2026
  • New genetic discovery on sudden cardiac death in the young

    Researchers at the Centenary Institute have helped uncover a previously unrecognised genetic cause of sudden cardiac death in young people.
    News Type: Research News
    Date 16 Apr 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram